ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
21.75
-0.58 (-2.60%)
Apr 25, 2025, 12:45 PM EDT - Market open

ADMA Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
5,1684,0541,021857276184
Upgrade
Market Cap Growth
296.93%296.93%19.17%210.44%49.75%-22.30%
Upgrade
Enterprise Value
5,1494,0791,100975343225
Upgrade
Last Close Price
22.3317.154.523.881.411.95
Upgrade
PE Ratio
26.8620.51----
Upgrade
Forward PE
31.8825.2836.16---
Upgrade
PS Ratio
12.209.513.965.563.414.37
Upgrade
PB Ratio
15.1411.627.555.641.962.09
Upgrade
P/TBV Ratio
14.9911.757.795.812.032.24
Upgrade
P/FCF Ratio
46.8136.71253.51---
Upgrade
P/OCF Ratio
43.5734.16116.07---
Upgrade
EV/Sales Ratio
12.089.564.266.334.245.33
Upgrade
EV/EBITDA Ratio
35.0227.7433.58---
Upgrade
EV/EBIT Ratio
37.0529.3545.03---
Upgrade
EV/FCF Ratio
46.6236.93273.07---
Upgrade
Debt / Equity Ratio
0.240.241.051.020.731.11
Upgrade
Debt / EBITDA Ratio
0.550.554.02---
Upgrade
Debt / FCF Ratio
0.740.7435.10---
Upgrade
Asset Turnover
1.041.040.760.490.340.25
Upgrade
Inventory Turnover
1.211.211.000.830.770.80
Upgrade
Quick Ratio
2.762.761.582.602.623.47
Upgrade
Current Ratio
5.975.975.166.896.877.71
Upgrade
Return on Equity (ROE)
81.64%81.64%-19.67%-44.96%-62.46%-132.38%
Upgrade
Return on Assets (ROA)
21.24%21.24%4.51%-7.88%-14.87%-21.44%
Upgrade
Return on Capital (ROIC)
24.55%24.55%5.24%-8.94%-16.74%-24.18%
Upgrade
Return on Capital Employed (ROCE)
32.10%32.10%8.70%---
Upgrade
Earnings Yield
3.82%4.88%-2.77%-7.69%-25.95%-41.09%
Upgrade
FCF Yield
2.14%2.72%0.39%-8.57%-45.59%-62.23%
Upgrade
Buyback Yield / Dilution
-8.65%-8.65%-13.19%-41.77%-62.03%-58.51%
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q